Division of Hematology and Oncology, Department of Medicine, Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee.
Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
Clin Cancer Res. 2021 Feb 1;27(3):831-842. doi: 10.1158/1078-0432.CCR-20-0557. Epub 2020 Nov 4.
The objective of this study is to characterize the role of miRNAs in the classification of head and neck squamous cell carcinoma (HNSCC).
Here, we analyzed 562 HNSCC samples, 88 from a novel cohort and 474 from The Cancer Genome Atlas, using miRNA microarray and miRNA sequencing, respectively. Using an integrative correlations method followed by miRNA expression-based hierarchical clustering, we validated miRNA clusters across cohorts. Evaluation of clusters by logistic regression and gene ontology approaches revealed subtype-based clinical and biological characteristics.
We identified two independently validated and statistically significant ( < 0.01) tumor subtypes and named them "epithelial" and "stromal" based on associations with functional target gene ontology relating to differing stages of epithelial cell differentiation. miRNA-based subtypes were correlated with individual gene expression targets based on miRNA seed sequences, as well as with miRNA families and clusters including the miR-17 and miR-200 families. These correlated genes defined pathways relevant to normal squamous cell function and pathophysiology. miRNA clusters statistically associated with differential mutation patterns including higher proportions of mutations in the stromal class and higher and mutation frequencies in the epithelial class. miRNA classes correlated with previously reported gene expression subtypes, clinical characteristics, and clinical outcomes in a multivariate Cox proportional hazards model with stromal patients demonstrating worse prognoses (HR, 1.5646; = 0.006).
We report a reproducible classification of HNSCC based on miRNA that associates with known pathologically altered pathways and mutations of squamous tumors and is clinically relevant.
本研究旨在探讨 miRNA 在头颈部鳞状细胞癌(HNSCC)分类中的作用。
我们分别使用 miRNA 微阵列和 miRNA 测序分析了 562 例 HNSCC 样本,其中 88 例来自新队列,474 例来自癌症基因组图谱。采用整合相关方法结合基于 miRNA 表达的层次聚类,我们验证了队列间的 miRNA 簇。通过逻辑回归和基因本体分析评估聚类,揭示了基于亚型的临床和生物学特征。
我们确定了两个独立验证且具有统计学意义的(<0.01)肿瘤亚型,并根据与上皮细胞分化不同阶段相关的功能靶基因本体论的关联,将其命名为“上皮”和“基质”。基于 miRNA 种子序列的单个基因表达靶标、miRNA 家族和簇(包括 miR-17 和 miR-200 家族),miRNA 亚型与个体基因表达靶标相关。这些相关基因定义了与正常鳞状细胞功能和病理生理学相关的途径。miRNA 簇与差异突变模式统计学相关,包括基质类中更高比例的突变和上皮类中更高的突变和突变频率。miRNA 类与先前报道的基因表达亚型、临床特征和多变量 Cox 比例风险模型中的临床结果相关,其中基质患者的预后更差(HR,1.5646;=0.006)。
我们报告了一种基于 miRNA 的 HNSCC 可重现分类,其与已知的病理改变途径和鳞状肿瘤的突变相关,并且具有临床相关性。